Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2022

Zinzino
Download the release

Zinzino group revenue increased with a total of 6% in Q4 and 5% for the full year 2022, compared with the previous year.

The revenue in December for Zinzino's sales markets decreased by 16% and amounted to SEK 120.2 (143.8) million. Faun Pharma's external sales decreased by 4% and amounted to SEK 5.0 (5.2) million. Overall, the Group decreased revenues by 16% to SEK 125.2 (149.0) million compared with the previous year.

Sales in Zinzino's sales markets increased by 6% in the fourth quarter of 2022 compared with the same period last year and amounted to SEK 409.7 (386.1) million. Total revenues in the Group increased by 6% in the fourth quarter and amounted to SEK 425.5 (401.2) million.

Accumulated revenue for January - December 2022 increased by 5% compared with the same period last year and amounted to SEK 1439.3 (1370.6) million.

Revenues were distributed as follows:

Regions, 22 21 Change Q4 Q4 Change YTD YTD Change
mSEK -dec -dec 2022 2021 2022 2021
The 31.0 36.4 -15% 87.7 98.9 -11% 323.4 369.8 -13%
Nordics
Central 27.6 27.5 0% 94.1 70.2 34% 290.6 232.7 25%
Europe
East 27.1 32.2 -16% 103.5 99.1 4% 341.3 337.1 1%
Europe
South & 14.8 16.8 -12% 50.5 44.2 14% 164.5 147.1 12%
West
Europe
The 7.1 10.4 -32% 25.2 27.0 -7% 77.8 79.2 -2%
Baltics
North 5.7 6.1 -7% 25.2 15.2 66% 77.2 51.3 50%
America
Asia 5.6 13.9 -60% 19.6 30.4 -36% 77.3 89.7 -14%
-Pacific
Africa 1.3 0.5 160% 3.9 1.1 255% 10.1 1.1 818%
Zinzino 120.2 143.8 -16% 409.7 386.1 6% 1362.2 1308.0 4%
Faun 5.0 5.2 -4% 15.8 15.1 5% 77.1 62.6 23%
Pharma
Zinzino 125.2 149.0 -16% 425.5 401.2 6% 1439.3 1370.6 5%
Group

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:00 the 4th of January 2023.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.